Abeona Therapeutics Inc banner

Abeona Therapeutics Inc
F:PCJP

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
F:PCJP
Watchlist
Price: 0.1145 EUR 6.61%
Market Cap: €28.7m

Wall St Price Targets

PCJP Price Targets Summary
Abeona Therapeutics Inc

Wall Street analysts forecast PCJP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCJP is 0.3284 EUR with a low forecast of 0.231 EUR and a high forecast of 0.4802 EUR.

Lowest Forecast
Price Target
0.231 EUR
102% Upside
Average Forecast
Price Target
0.3284 EUR
187% Upside
Highest Forecast
Price Target
0.4802 EUR
319% Upside
Abeona Therapeutics Inc Competitors:
Price Targets
FULT
Fulton Financial Corp
0% Upside
LGI
Lgi Ltd
72% Upside
NYXH
Nyxoah SA
283% Upside

Revenue
Forecast

9% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
9% / Year
Past Growth
71% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.

Gross Profit
Forecast

7% / Year
Past Growth
280% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
7% / Year
Past Growth
280% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 280%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
-22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
-22% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.

Net Income
Forecast

N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Net Income over the next 8 years is 18%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PCJP's stock price target?
Price Target
0.3284 EUR

According to Wall Street analysts, the average 1-year price target for PCJP is 0.3284 EUR with a low forecast of 0.231 EUR and a high forecast of 0.4802 EUR.

What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%

Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.

What is the Gross Profit forecast for Abeona Therapeutics Inc?
Projected CAGR
280%

Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 280%.

What is the Pre-Tax Income forecast for Abeona Therapeutics Inc?
Projected CAGR
-22%

The compound annual growth rate for Pre-Tax Income over the next 3 years is -22%.

What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
18%

The compound annual growth rate for Net Income over the next 8 years is 18%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett